Chapter 12: Shock, Sepsis, and Multiple Organ Dysfunction Syndrome

Shock represents a critical clinical emergency characterized by inadequate tissue perfusion that disrupts cellular oxygen supply and triggers a cascade of metabolic derangements. When tissues cannot maintain aerobic metabolism, cells shift to anaerobic pathways, producing insufficient energy while accumulating lactic acid that causes tissue acidosis and progressive cellular injury. The chapter traces shock through four distinct progression stages, beginning with an initial phase where cardiac output diminishes subclinically, followed by a compensatory stage in which neural, endocrine, and chemical mechanisms attempt to restore homeostasis through catecholamine release, renin-angiotensin-aldosterone system activation, and hyperventilation. As compensatory mechanisms fail during the progressive stage, profound hypoperfusion triggers metabolic acidosis, cellular edema from sodium-potassium pump dysfunction, and inflammatory mediator release. The refractory stage represents irreversible shock unresponsive to therapeutic intervention, culminating in tissue ischemia and multiple organ dysfunction. The chapter categorizes shock into four primary types based on underlying circulatory mechanisms: hypovolemic shock from inadequate intravascular volume due to hemorrhage or dehydration requires aggressive fluid resuscitation; cardiogenic shock from cardiac pump failure typically follows myocardial infarction and demands inotropic support and afterload reduction; obstructive shock from physical blockade of blood flow necessitates removal of the obstructing source; and distributive shock from widespread vasodilation includes neurogenic shock from sympathetic nervous system loss, anaphylactic shock from severe allergic reactions, and septic shock from dysregulated host response to infection. Nursing assessment emphasizes monitoring organ systems vulnerable to hypoperfusion, including central nervous system responsiveness, cardiovascular hemodynamics, renal perfusion indicated by urine output, and laboratory markers such as serum lactate elevation and arterial pH decline. Management priorities focus on identifying the underlying cause, restoring tissue perfusion through fluid therapy and vasopressor support, optimizing oxygen delivery, and providing organ-specific supportive care including mechanical ventilation and nutritional support. Multiple organ dysfunction syndrome emerges as the progressive failure of two or more organ systems, either from direct injury or secondary to systemic inflammatory response, with mortality increasing substantially as additional organs fail.